Mode
Text Size
Log in / Sign up

Lactated Ringer's reduces progression to severe acute pancreatitis and local complications compared to normal salineLactated Ringer's May Lower Severe Pancreatitis Risk Compared to Normal Saline

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider Lactated Ringer's over normal saline to reduce progression to severe acute pancreatitis and local complications.

This systematic review and component network meta-analysis evaluated the efficacy of various hydration strategies, including Lactated Ringer's (LR), normal saline (NS), and other balanced multi-electrolyte solutions (BMES), in patients with new-onset acute pancreatitis. The analysis included a total of 1216 patients to compare these fluids and the impact of aggressive versus non-aggressive resuscitation.

Key findings indicate that LR significantly reduced progression to moderately severe or severe acute pancreatitis (iOR 0.51; 95% CI 0.33; 0.79) and significantly reduced pancreatitis-related local complications (iOR 0.53; 95% CI 0.33; 0.85) compared to NS. Additionally, both BMES and LR were associated with a reduction in length of stay (LOS) by approximately 4 and 1 day, respectively, when compared to NS. However, aggressive resuscitation was associated with a higher risk of adverse events (iOR 3.35; 95% CI 1.52; 7.37).

The authors note that the certainty of evidence is generally low to moderate due to risk of bias and imprecision. Clinically, balanced crystalloids like LR are associated with improved outcomes in early management, while aggressive fluid regimens may increase adverse events without clear benefit. These findings suggest a preference for balanced fluids over normal saline in early acute pancreatitis management.

How this fits prior evidence

This finding addresses a gap in the management of acute pancreatitis by comparing specific hydration fluids. While previous evidence noted that microbiota-directed interventions reduce hospital stay and infection risk, this study specifically identifies Lactated Ringer's as a superior alternative to normal saline for reducing progression to severe disease and local complications. It also provides specific data on the risks of aggressive resuscitation, which was associated with a higher rate of adverse events (iOR 3.35).

A new review pooled data from 1,216 patients with new-onset acute pancreatitis to compare different types of IV fluids used early in treatment. The researchers looked at Lactated Ringer's, normal saline, other balanced solutions, and how aggressively fluids were given.

People given Lactated Ringer's had about a 49% lower chance of progressing to moderately severe or severe pancreatitis compared with normal saline. They also had about a 47% lower chance of local complications such as fluid collections or tissue damage around the pancreas.

Balanced solutions and Lactated Ringer's also shortened hospital stays, by roughly 4 days and 1 day respectively, compared with normal saline.

Giving fluids aggressively (large volumes quickly) raised the chance of side effects by more than three times, without a clear benefit. The review authors say the evidence quality is low to moderate, so results should be interpreted with some caution.

Overall, balanced fluids, especially Lactated Ringer's, appear linked to better outcomes than normal saline in early acute pancreatitis, while aggressive fluid regimens may cause more harm than good.

What this means for you:
Lactated Ringer's may reduce severe pancreatitis and complications versus normal saline, but aggressive fluids raise side effects.

Common questions

What is lactated Ringer's and how is it different from normal saline?

Both are IV fluids given in the hospital. Normal saline is salt water. Lactated Ringer's is a balanced fluid with several electrolytes. This review found lactated Ringer's was linked to fewer severe pancreatitis cases and fewer local complications than normal saline. It is a common, widely used fluid, but ask your doctor which is right for you.

Does giving more IV fluid help pancreatitis?

Not necessarily. This review found that aggressive resuscitation increased adverse events (iOR 3.35, 95% CI 1.52 to 7.37) without a clear benefit. That means pushing large amounts of fluid fast may cause harm. The type of fluid and the pace both seem to matter. Your care team will decide the right plan for your situation.

How strong is the evidence for lactated Ringer's in pancreatitis?

It is low to moderate certainty. The review pooled randomized trials covering 1,216 patients, but risk of bias and imprecision held back confidence. The results show associations, not proof of cause and effect. That makes the findings promising but not definitive. Talk with your doctor about what it means for your care.

Who does this apply to?

The review looked at patients with new-onset acute pancreatitis. It does not cover chronic pancreatitis or other conditions. If you are being treated for acute pancreatitis, ask your care team whether a balanced fluid like lactated Ringer's fits your treatment plan.

Study Details

Study typeSystematic review
Sample sizen = 1,216
EvidenceLevel 1
PublishedNov 2026
View Original Abstract ↓
BACKGROUND: Acute pancreatitis (AP) frequently requires early fluid resuscitation to restore intravascular volume, preserve pancreatic perfusion, and prevent organ failure. However, the optimal fluid type and resuscitation strategy remain controversial. METHODS: We performed a component network meta-analysis (CNMA) of randomized controlled trials comparing fluids (normal saline [NS], lactated Ringer [LR], other balanced multi-electrolyte solutions [BMES], and naso-jejunal hydration solution [NJ]) and resuscitation strategies (aggressive vs. non-aggressive) in patients with new-onset AP. Primary endpoints were progression to moderately severe or severe AP, systemic inflammatory response syndrome (SIRS), and adverse events. Secondary endpoints included mortality, local complications, organ failure, and length of stay (LOS). Incremental component effects were expressed as incremental odds ratios (iOR) or mean differences (iMD). Certainty of evidence was evaluated using CINeMA and GRADE. RESULTS: Twelve trials (1216 patients) were included. LR significantly reduced progression to moderately severe/severe AP (iOR 0.51; 95% CI 0.33; 0.79) and pancreatitis-related local complications (iOR 0.53; 95% CI 0.33; 0.85). BMES and LR reduced LOS by approximately 4 and 1 day, respectively, compared with NS. Aggressive resuscitation increased adverse events (iOR 3.35; 95% CI 1.52; 7.37). Heterogeneity and inconsistency were generally low for primary endpoints. CONCLUSIONS: Balanced crystalloids, particularly LR, are associated with improved clinical outcomes compared with NS in early AP management, reducing disease progression, local complications, and hospital stay. Aggressive fluid regimens increase adverse events without a clear benefit. These findings support the preferential use of LR within a moderate, goal-directed resuscitation strategy, although the certainty of evidence was generally low to moderate due to risk of bias and imprecision.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.